References
Said S.I., Mutt V. Polypeptide with broad biological activity: isolation from small intestine. Science 169: 1217, 1970.
Said S.I. VIP overview. In: Bloom S.R., Polak J.M. (Eds.), Gut hormones. Churchill Livingstone, Edinburgh, 1981, p. 379.
Said S.I., Giachetti A., Nicosia S. VIP: possible functions as a neural peptide. In: Costa E., Trabucchi M. (Eds.), Neural peptides and neuronal communication. Raven Press, New York, 1980, p. 75.
Nicosia S., Spada A., Giannattasio G. Effects of Vasoactive Intestinal Polypeptide on the pituitary gland. In: Said S.I. (Ed.), Vasoactive Intestinal Peptide. Raven Press, New York, 1982, p. 263.
Said S.I., Porter J.C. Vasoactive Intestinal Polypeptide: release into hypophyseal portal blood. Life Sci. 24: 227, 1979.
Shimatsu A., Kato Y., Matsushita N., Katakami H., Yanaihara N., Imura H. Immunoreactive Vasoactive Intestinal Polypeptide in rat hypophysial protal blood. Endocrinology 108: 395, 1981.
Said S.I., Rosenberg R.N. Vasoactive Intestinal Polypeptide; abundant immuno-reactivity in neural cell lines and normal nervous tissue. Science 192: 907, 1976.
Giachetti A., Said S.I., Reynolds R.C., Koniges F.C. Vasoactive Intestinal Polypeptide in brain: localization in and release from isolated nerve terminals. Proc. Natl. Acad. Sci. USA 74: 3424, 1977.
Fahrenkrug J., Schaffalitzky de Muckadell O.B. Distribution of Vasoactive Intestinal Polypeptide (VIP) in the porcine central nervous system. J. Neurochem. 31: 1445, 1978.
Besson J., Rotsztejn W., Laburthe M., Epelbaum J., Beaudet A., Kordon C., Rosselin G. Vasoactive Intestinal Peptide (VIP): brain distribution, subcellular localization and effect of deafferentation of the hypothalamus in male rats. Brain Res. 165: 79, 1979.
Loren I., Emson P.C., Fahrenkrug J., Björklund A., Alumets J., Hakanson R., Sundler F. Distribution of Vasoactive Intestinal Polypeptide in the rat and mouse brain. Neuroscience 4: 1953, 1979.
Samson W.K., Said S.I., McCann S.M. Radioimmunologic localization of Vasoactive Intestinal Polypeptide in hypothalamic and extrahypothalamic sites in the rat brain. Neurosci. Lett. 12: 265, 1979.
Sims K.B., Hoffman D.L., Said S.I., Zimmerman E.A. Vasoactive Intestinal Polypeptide (VIP) in mouse and rat brain: an immunocytochemical study. Brain Res. 186: 165, 1980.
Samson W.K., Said S.I., Graham J.W., McCann S.M. Vasoactive Intestinal Polypeptide concentrations in median eminence of hypothalamus. Lancet II: 901, 1978.
Emson P.C., Fahrenkrug J., Spokes E.G.S. Vasoactive Intestinal Polypeptide (VIP): distribution in normal human brain and in Huntington’s disease. Brain Res. 173: 174, 1979.
Vijayan E., Samson W.K., Said S.I., McCann S.M. Vasoactive Intestinal Peptide: evidence for a hypothalamic site of action to release growth hormone, luteinizing hormone, and prolactin in conscious ovariectomized rats. Endocrinology 104: 53, 1979.
Ruberg M., Rotsztejn W.K, Arancibia S., Besson J., Enjalbert A. Stimulation of prolactin release by Vasoactive Intestinal Peptide (VIP). Eur. J. Pharmacol. 51: 319, 1978.
Enjalbert A., Arancibia S., Ruberg M., Priam M., Bluet-Pajot M.T., Rotsztejn W.K., Kordon C. Stimulation of in vitro prolactin release by Vasoactive Intestinal Peptide. Neuroendocrinology 31: 200, 1980.
Rotsztejn W.K., Benoist L., Besson J., Beraud G., Bluet-Pajot M.T., Kordon C., Rosselin G., Duval J. Effect of Vasoactive Intestinal Peptide (VIP) on the release of adenohypophyseal hormones from purified cells obtained by unit gravity sedimentation. Neuroendocrinology 31: 282, 1980.
Samson W.K., Koning J., Reeves J., McCann S.M. Vasoactive Intestinal Polypeptide stimulates LHRH release from hypothalamic synaptosomes. Proceedings of the 62nd Annual Meeting of the Endocrine Society, p. 261, 1980. (Abstract).
Epelbaum J., Tapia-Arancibia L., Besson J., Rotsztejn W.H., Kordon C. Vasoactive Intestinal Peptide inhibits release of somatostatin from hypothalamus in vitro. Eur. J. Pharmacol. 58: 493, 1979.
Enjalbert A., Epelbaum J., Arancibia S., Tapia-Arancibia L., Bleut-Pajot M., Kordon C. Reciprocal interactions of somatostatin with thyrotropin-releasing hormone and vasoactive intestinal peptide on prolactin and growth hormone secretion in vitro. Endocrinology 111: 42, 1982.
Matsushita N., Kato Y., Katakami H., Shimatsu A., Yanaihara N., Imura H. Stimulation of growth hormone release by vasoactive intestinal polypeptide from human pituitary adenomas in vitro. J. Clin. Endocrinol. Metab. 53:1297, 1981.
Chihara K., Iwasaki J., Minamitani N., Kaji H., Matsukura S., Tamaki N, Matsumoto S., Fujita T. Effect of Vasoactive Intestinal Polypeptide on growth hormone secretion in perifused acromegalic pituitary adenoma tissues. J. Clin. Endocrinol. Metab. 54: 773, 1982.
Faglia G., Beck-Peccoz P., Ferrari C., Travaglini P., Ambrosi B., Spada A. Plasma growth hormone response to thyrotropin-releasing hormone in patients with active acromegaly. J. Clin. Endocrinol. Metab. 36: 1259, 1973.
Rubin A.L., Levin S.R., Bernstein R.I., Tyrrell J.B., Noacco C., Forsham P.M. Stimulation of growth hormone by luteinizing hormone-releasing hormone in active acromegaly. J. Clin. Endocrinol. Metab. 37: 160, 1973.
Liuzzi A., Chiodini P.G., Botalla L., Cremascoli G., Silvestrini F. Inhibitory effect of L-dopa on GH release in acromegalic patients. J. Clin. Endocrinol. Metab. 35: 941, 1972.
Kato Y., Iwasaki Y., Iwasaki J., Abe H., Yanaihara N., Imura H. Prolactin release by Vasoactive Intestinal Polypeptide in rats. Endocrinology 103: 554, 1978.
Shaar C.J., Clemes J.A., Dininger N.B. Effect of Vasoactive Intestinal Polypeptide on prolactin release in vitro. Life Sci. 25: 2071, 1979.
Samson W.K., Said S.I., Snyder G., McCann S.M. In vitro stimulation of-prolactin release by Vasoactive Intestinal Peptide. Peptides 1: 325, 1980.
Gourdji D., Bataille D., Vauclin N., Grouselle D., Rosselin G., Tixier-Vidal A. Vasoactive Intestinal Peptide (VIP) stimulates prolactin (PRL) release and cAMP production in a rat pituitary cell line (GH3/B6). Additive effects of VIP and TRH on PRL release. FEBS Lett. 104: 165, 1979.
Fawley L.S., Neill J.D. Stimulation of prolactin secretion in rhesus monkeys by Vasoactive Intestinal Polypeptide. Neuroendocrinology 33: 79, 1981.
Bataille D., Talbot J.N., Milhaud G., Mutt V., Rosselin G. Effect du peptide intestinal vasoactif (VIP) sur la secretion de prolactine chez I’homme. C.R. Acad. Sc. Paris 292: 511, 1981.
Ottesen B., Andersen A.N., Gerstenberg T., Ulrichsen H., Manthorpe T., Fahrenkrug J. VIP stimulates prolcatin release in women. Lancet II, 696, 1981.
Malarkey W.B., O’Dorisio T.M., Kennedy M., Cataland S. The influence of Vasoactive Intestinal Polypeptide and chelocystokinin on prolactin release in rat and human monolayer cultures. Life Sci., 28: 2489, 1981.
Nicosia S., Spada A., Borghi C., Cortelazzi L., Giannattasio G. Effects of Vasoactive Intestinal Polypeptide (VIP) in human prolactin (PRL) secreting pituitary adenomas. Stimulation of PRL release and activation of adenylate cyclase. FEBS Lett. 112: 159, 1980.
Spada A., Nicosia S., Cortelazzi L., Pezzo G., Bassetti M., Sartorio A., Giannattasio G. In vitro studies on prolactin release and adenylate cyclase activity in human prolactin-secreting pituitary adenomas. Different sensitivity of macro and microadenomas to dopamine and vasoactive intestinal poplypeptide. J. Clin. Endocrinol. Metab. 56: 1, 1983.
McLeod R.M. Regulation of prolactin secretion. In: Martini L., Ganong W.F. (Eds.), Frontiers in neuroendocrinology. Raven Press, New York, 1976, vol. 4, p. 169.
Drouin J., De Lean A., Rainville D., Lachance R., Labrie F. Characteristics of the interaction between thyrotropin releasing hormone and somatostatin for thyrotropin and prolactin release. Endocrinology 98: 514, 1976.
Rotsztejn W.H., Dussaillant M, Nobou F., Rosselin G. Rapid glucorticoid inhibition of vasoactive intestine peptide-induced cyclic AMP accumulation and prolactin release in rat pituitary cells in culture. Proc. Natl. Acad. Sci. USA 78: 7584, 1981.
Oliva D., Nicosia S., Spada A., Giannattasio G. VIP stimulates ACTH release and adenylate cyclase in human ACTH-secreting pituitary adenomas. Eur. J. Pharmacol. 83: 101, 1982.
Salmon Y., Londos C., Rodbell M. A highly sensitive adenylate cyclase assay. Anal. Biochem. 58: 541, 1974.
Labrie F., Borgeat P., Drouin J., Beaulieu M, Lagace L., Ferland L., Raymond V. Mechanism of action of hypothalamic hormones in the adenohypophysis. Annu. Rev. Physiol. 41: 555, 1979.
Borghi C., Nicosia S., Giachetti A., Said S.I. Adenylate cyclase of rat pituitary gland. Stimulation by Vasoactive Intestinal Polypeptide (VIP). FEBS Lett. 108: 403, 1979.
Robberecht P., Deschodt-Lanckman M., Camus J.-C., De Neef P., Lambert M, Christophe J. VIP activation of rat anterior pituitary adenylate cyclase. FEBS Lett. 103: 229, 1979.
De Camilli P., Zanini A., Giannattasio G., Meldolesi J. Synthesis, intracellular transport, packaging and release of growth hormone and prolactin in normal and tumoral pituitary cells. In: Faglia G., Giovanelli M.A., Me Leod R.M. (Eds.), Pituitary microadenomas. Academic Press, London, 1980, p. 55.
Bataille D., Peillon F., Besson J., Rosselin G. Vasoactive Intestinal Peptide (VIP): recepteurs specifiques et activation de I’adenylate cyclase dans une tumeur hypophysaire humaine a prolactine. C.R. Acad. Sc. Paris 288: 1315, 1979.
Onali P., Schwartz J.P., Costa E. Dopaminergic modulation of adenylate cyclase stimulation by vasoactive intestinal peptide in anterior pituitary. Proc. Natl. Acad. Sci. USA 78: 6531, 1981.
De Camilli P., Macconi D., Spada A. Dopamine inhibits adenylate cyclase in human prolactin-secreting pituitary adenomas. Nature 278: 252, 1979.
Maurer R.A. Transcriptional regulation of the prolactin gene by ergocryptine and cyclic AMP. Nature 294: 94, 1981.
Szabo M., Frohman L.A. Dissociation of prolactin-releasing activity from thyrotropin-releasing hormone in porcine stalk median eminence. Endocrinology 98: 1451, 1976.
Chiocchio S.A., Cannata M.A., Corderofunes J.R., Tramezzani J.H. Involvement of adenohypophyseal dopamine in the regulation of prolactin release during suckling. Endocrinology 105: 544, 1979.
Fine S.A., Frohman L.A. Loss of central nervous system component of dopaminergic inhibition of prolactin secretion in patients with prolactin-secreting pituitary tumors. J. Clin. Invest. 61: 973, 1978.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Nicosia, S., Oliva, D., Giannattasio, G. et al. The role of vasoactive intestinal polypeptide (VIP) as a hypothalamic neurohormone. J Endocrinol Invest 6, 235–242 (1983). https://doi.org/10.1007/BF03350614
Published:
Issue Date:
DOI: https://doi.org/10.1007/BF03350614